Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1995 Dec;115(3):411–418. doi: 10.1017/s0950268800058568

Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic.

P Kriz 1, J Vlckova 1, M Bobak 1
PMCID: PMC2271609  PMID: 8557072

Abstract

Vaccination against Neisseria meningitidis is not part of routine immunization schemes in any country; instead, targeted vaccination of groups at the highest risk is recommended during outbreaks and epidemics. After a long period of sporadic occurrence of meningococcal invasive disease, a new clone of Neisseria meningitidis C:2a:P1.2, ET-15/37, occurred in the Czech Republic, and caused local outbreaks in two neighbouring districts, Olomouc and Bruntal, in spring 1993. In Olomouc, a mass campaign was conducted during which 6191 students were vaccinated (5.6% of the total population of this locality and 96% of all students in the age group 15-19) within 2 weeks in June 1993. In Bruntal district, no such campaign was organized. In Olomouc, the incidence of invasive disease caused by Neisseria meningitidis C in the age group 10-24 decreased from 57 to 0 per 100,000 (P < 0.001) during the post-vaccination period (July 1993-August 1994), but no such decrease was observed in Bruntal. Although other factors can affect the frequency of disease, these results support the current recommendations of targeted vaccination in outbreaks of meningococcal disease.

Full text

PDF
411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdillahi H., Poolman J. T. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol Immunol. 1988 Dec;1(3):139–144. doi: 10.1111/j.1574-6968.1988.tb02366.x. [DOI] [PubMed] [Google Scholar]
  2. Ashton F. E., Ryan A., Diena B., Jennings H. J. A new serogroup (L) of Neisseria meningitidis. J Clin Microbiol. 1983 May;17(5):722–727. doi: 10.1128/jcm.17.5.722-727.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashton F. E., Ryan J. A., Borczyk A., Caugant D. A., Mancino L., Huang D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol. 1991 Nov;29(11):2489–2493. doi: 10.1128/jcm.29.11.2489-2493.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BRANHAM S. E. Serological relationships among meningococci. Bacteriol Rev. 1953 Sep;17(3):175–188. doi: 10.1128/br.17.3.175-188.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bohr V., Hansen B., Kjersem H., Rasmussen N., Johnsen N., Kristensen H. S., Jessen O. Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns. Part II of a three part series. J Infect. 1983 Sep;7(2):102–110. doi: 10.1016/s0163-4453(83)90443-7. [DOI] [PubMed] [Google Scholar]
  6. Cartwright K. A., Stuart J. M., Noah N. D. An outbreak of meningococcal disease in Gloucestershire. Lancet. 1986 Sep 6;2(8506):558–561. doi: 10.1016/s0140-6736(86)90124-8. [DOI] [PubMed] [Google Scholar]
  7. Caugant D. A., Frøholm L. O., Bøvre K., Holten E., Frasch C. E., Mocca L. F., Zollinger W. D., Selander R. K. Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4927–4931. doi: 10.1073/pnas.83.13.4927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ceesay S. J., Allen S. J., Menon A., Todd J. E., Cham K., Carlone G. M., Turner S. H., Gheesling L. L., DeWitt W., Plikaytis B. D. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis. 1993 May;167(5):1212–1216. doi: 10.1093/infdis/167.5.1212. [DOI] [PubMed] [Google Scholar]
  9. Cuevas L. E., Hart C. A. Chemoprophylaxis of bacterial meningitis. J Antimicrob Chemother. 1993 Feb;31 (Suppl B):79–91. doi: 10.1093/jac/31.suppl_b.79. [DOI] [PubMed] [Google Scholar]
  10. Ding S. Q., Ye R. B., Zhang H. C. Three new serogroups of Neisseria meningitidis. J Biol Stand. 1981;9(3):307–315. doi: 10.1016/s0092-1157(81)80056-x. [DOI] [PubMed] [Google Scholar]
  11. Evans J. R., Artenstein M. S., Hunter D. H. Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol. 1968 May;87(3):643–646. doi: 10.1093/oxfordjournals.aje.a120854. [DOI] [PubMed] [Google Scholar]
  12. Frasch C. E., Zollinger W. D., Poolman J. T. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis. 1985 Jul-Aug;7(4):504–510. doi: 10.1093/clinids/7.4.504. [DOI] [PubMed] [Google Scholar]
  13. Grahlow W. D., Kuzemenská P. Meningitis in a child due to Neisseria meningitidis group K. Infection. 1989 Sep-Oct;17(5):309–310. doi: 10.1007/BF01650715. [DOI] [PubMed] [Google Scholar]
  14. Greenwood B. M., Bradley A. K., Smith A. W., Wall R. A. Mortality from meningococcal disease during an epidemic in The Gambia, West Africa. Trans R Soc Trop Med Hyg. 1987;81(4):536–538. doi: 10.1016/0035-9203(87)90397-x. [DOI] [PubMed] [Google Scholar]
  15. Greenwood B. M., Wali S. S. Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet. 1980 Apr 5;1(8171):729–732. doi: 10.1016/s0140-6736(80)91230-1. [DOI] [PubMed] [Google Scholar]
  16. Halstensen A., Pedersen S. H., Haneberg B., Bjorvatn B., Solberg C. O. Case fatality of meningococcal disease in western Norway. Scand J Infect Dis. 1987;19(1):35–42. doi: 10.3109/00365548709032375. [DOI] [PubMed] [Google Scholar]
  17. Jackson L. A., Schuchat A., Reeves M. W., Wenger J. D. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA. 1995 Feb 1;273(5):383–389. [PubMed] [Google Scholar]
  18. Krízová-Kuzemenská P., Benes C., Dlhy J., Kartusek S., Matuska J., Vlcková J., Galetková A., Roznovský L. Zvýsený výskyt invazívního meningokokového onemocnení v nekterých oblastech Ceské republiky způsobený meningokokem C:2a:P1.2. Cesk Epidemiol Mikrobiol Imunol. 1993 Dec;42(4):165–171. [PubMed] [Google Scholar]
  19. Krízová P., Musílek M., Lebedová V. Nová epidemiologická situace v Ceské republice způsobená meningokokem C:2a:P1.2 (P1.5). Epidemiol Mikrobiol Imunol. 1994 Dec;43(4):183–187. [PubMed] [Google Scholar]
  20. Käyhty H., Karanko V., Peltola H., Sarna S., Mäkelä P. H. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis. 1980 Dec;142(6):861–868. doi: 10.1093/infdis/142.6.861. [DOI] [PubMed] [Google Scholar]
  21. Lennon D., Gellin B., Hood D., Voss L., Heffernan H., Thakur S. Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand. Pediatr Infect Dis J. 1992 Aug;11(8):617–623. [PubMed] [Google Scholar]
  22. Lepow M. L., Goldschneider I., Gold R., Randolph M., Gotschlich E. C. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics. 1977 Nov;60(5):673–680. [PubMed] [Google Scholar]
  23. Moore P. S., Toole M. J., Nieburg P., Waldman R. J., Broome C. V. Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull World Health Organ. 1990;68(5):587–596. [PMC free article] [PubMed] [Google Scholar]
  24. Mäkelä P. H., Käyhty H., Weckström P., Sivonen A., Renkonen O. V. Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet. 1975 Nov 8;2(7941):883–886. doi: 10.1016/s0140-6736(75)92125-x. [DOI] [PubMed] [Google Scholar]
  25. Peltola H. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis. 1978;10(1):41–44. doi: 10.3109/inf.1978.10.issue-1.09. [DOI] [PubMed] [Google Scholar]
  26. Peltola H., Mäkelä H., Käyhty H., Jousimies H., Herva E., Hällström K., Sivonen A., Renkonen O. V., Pettay O., Karanko V. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med. 1977 Sep 29;297(13):686–691. doi: 10.1056/NEJM197709292971302. [DOI] [PubMed] [Google Scholar]
  27. Reingold A. L., Broome C. V., Hightower A. W., Ajello G. W., Bolan G. A., Adamsbaum C., Jones E. E., Phillips C., Tiendrebeogo H., Yada A. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet. 1985 Jul 20;2(8447):114–118. doi: 10.1016/s0140-6736(85)90224-7. [DOI] [PubMed] [Google Scholar]
  28. Rønne T., Berthelsen L., Buhl L. H., Lind I. Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. Scand J Infect Dis. 1993;25(3):331–339. doi: 10.3109/00365549309008507. [DOI] [PubMed] [Google Scholar]
  29. Selander R. K., Caugant D. A., Ochman H., Musser J. M., Gilmour M. N., Whittam T. S. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986 May;51(5):873–884. doi: 10.1128/aem.51.5.873-884.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stroffolini T. Vaccination campaign against meningococcal disease in army recruits in Italy. Epidemiol Infect. 1990 Dec;105(3):579–583. doi: 10.1017/s0950268800048214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Whalen C. M., Hockin J. C., Ryan A., Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA. 1995 Feb 1;273(5):390–394. [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES